Embryo quality based on ovulation induction: Defining the differences

Reproductive BioMedicine Online

Volumn 11, Issue 1, 2005, Pages 22-25

  Racowsky, Catherine ^a   Orasanu, Bogdan ^a   Hinrichsen, Miguel J ^a,b   Ginsburg, Elizabeth S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Centre for Reproductive Medicine   (Germany)

Author keywords

Embryo quality; Oocyte quality; Ovarian stimulation; Recombinant FSH; Urinary FSH

Indexed keywords

ESTRADIOL; LEUPRORELIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; CRYOPRESERVATION; DRUG UTILIZATION; ECHOGRAPHY; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE MATURATION; OVULATION INDUCTION; PATIENT MONITORING; PREGNANCY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 21844441591     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61294-1     Document Type: Article

References (17)

1. Balasch J, Penarrubia J, Fabregues F et al. 2003 Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reproductive BioMedicine Online 7, 35-42.
2. Bergh C, Howles C, Borg K et al. 1997 Recombinant human follicle stimulating hormone (r-hFSH, Gonal F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Human Reproduction 12, 2133-2139.
3. Daya S, Gunby J 1999 Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Human Reproduction 14, 2207-2215.
4. Daya S, Gunby J 2004 Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. The Cochrane Database of Systematic Reviews, Update Software, Oxford, UK.
5. Fisch B, Avrech OM, Pinkas H 1995 Superovulation before IVF by recombinant versus urinary FSH (combined with a long GnRH analog protocol): a comparative study. Journal of Assisted Reproduction and Genetics 12, 26-31.
6. Giudice E, Crisci C, Altarocca V et al. 2001 Characterisation of a passisted reproductionially purified human menopausal gonadotropin preparation. Journal of Clinical Research 4, 27-33.
7. Homburg R, Armar NA, Eshel A et al. 1988 Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 297, 1024-1026.
8. Hoomans EHM, Andersen AN, Loft A et al. 1999 A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation. Human Reproduction 14, 2442-2447.
9. Howles CM, Macnamee MC, Edwards RG et al. 1986 Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 2, 521-522.
10. Lenton E, Soltan A, Hewitt J et al. 2000 Induction of ovulation in women undergoing assisted reproductive techniques: recombinant FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Human Reproduction 15, 1021-1027.
11. Out HJ, Mannaerts BMJL, Driessen SGAJ et al. 1996 Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Human Reproduction 12, 162-171.
12. Out HJ, Driessen SGAJ, Mannaerts BMJL et al. 1997 Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertility and Sterility 68, 138-142.
13. Regan L, Owen EJ, Jacobs HS 1990 Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 336, 1141-1144.
14. Schats R, De Sutter P, Bassil S et al. 2000 Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. Human Reproduction 15, 1691-1697.
15. Silverberg K 2002 Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA. Reproductive BioMedicine Online 5, 265-269.
16. Stanger JD, Yovich, JL 1985 Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. British Journal of Obstetrics and Gynaecology 92, 385-393.
17. van den Hooven H 2003 Compositional analyses of a human menopausal gonadotropin preparation extracted from urine (menotropin). Identification of some of its major impurities. Reproductive BioMedicine Online 7, 547-557.